Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response Meeting Abstract
| Authors: | Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; Kotecha, R.; Somai, S.; Boire, A.; Gavrilovic, I.; Piotrowski, A.; Wilcox, J.; Malani, R.; Young, R.; Offin, M.; Diamond, E.; Yang, J. |
| Abstract Title: | Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response |
| Meeting Title: | 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 25 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Nov 15-19 |
| Meeting Location: | Vancouver, Canada |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | v74 |
| Language: | English |
| ACCESSION: | WOS:001115245400290 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noad179.0289 |
| Notes: | Meeting Abstract: CTNI-07 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
